Why the study?
Does TEVAR improve aortic remodeling and survival in patients with acute and sub-acute uncomplicated type B aortic dissection with high-risk features compared to conservative treatment?
Does TEVAR improve aortic remodeling and survival in patients with acute and sub-acute uncomplicated type B aortic dissection with high-risk features compared to conservative treatment?
TEVAR promotes favorable aortic remodeling and demonstrates high midterm survival in patients with acute and subacute uncomplicated type B aortic dissection with high-risk features.
Answers are grounded in this paper and cite their sources.
Observational TEVAR data support remodeling in high-risk type B dissection; leaves open randomized comparison to medical therapy.
In a retrospective, single center analysis of prospectively collected data with follow-up, we compared 35 patients with high-risk features who recieved TEVAR in acute and sub-acute uncomplicated type B aortic dissection to a control-group (n=18). The TEVAR group showed a significant positive remoduling (reduction of max. aortic and false lumen diameter and increase of true lumen diameter (p<0.001 each)) during follow-up with an estimated survival of 94.1% after 3 years and 87.5% after 5 years.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: